RE:RE:RE:RE:Question about KNR share structureThis quote is from recent news:
------------------
Strengthened Balance Sheet and Discussions for Additional Government Funding
As of September 22, 2020, the Company has received approximately $1 Million in cash from the exercise of common share options and warrants which has strengthened Kontrol's balance sheet to advance BioCloud's commercialization.
--------------------
Do we know how many more Warrant & option shares are outstanding? Their exericise price and expiry date would be a good clue.